IRIS
CERCHIA, CARMEN
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 392
EU - Europa 240
AS - Asia 86
SA - Sud America 1
Totale 719
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 387
IT - Italia 158
CN - Cina 74
IE - Irlanda 32
FI - Finlandia 16
SE - Svezia 9
GB - Regno Unito 6
TR - Turchia 6
CA - Canada 5
FR - Francia 5
DE - Germania 4
VN - Vietnam 4
ES - Italia 3
RU - Federazione Russa 2
BE - Belgio 1
CL - Cile 1
CZ - Repubblica Ceca 1
GR - Grecia 1
IN - India 1
IR - Iran 1
LV - Lettonia 1
RS - Serbia 1
Totale 719
Salva come PNG Salva come JPEG
Città #
Chandler 93
Napoli 45
Millbury 43
Des Moines 29
Beijing 24
Princeton 20
Lawrence 16
Nanjing 15
Salerno 14
Boston 13
Wilmington 11
Naples 10
Hebei 6
Shenyang 6
Falls Church 5
Guangzhou 5
Ottawa 5
Dong Ket 4
Fairfield 4
Nanchang 4
Redwood City 4
Çanakkale 4
Busto Arsizio 3
Changsha 3
Jiaxing 3
Milan 3
Norwalk 3
Sevilla 3
Catanzaro 2
Dublin 2
Frankfurt am Main 2
Genova 2
Mablethorpe 2
Oristano 2
Pisa 2
Redmond 2
Siano 2
Stockholm 2
Tianjin 2
Yellow Springs 2
Ann Arbor 1
Ashburn 1
Atlanta 1
Belgrade 1
Belmonte Mezzagno 1
Benevento 1
Boardman 1
Bonn 1
Brussels 1
Caserta 1
Castellammare Di Stabia 1
Cava De' Tirreni 1
Cernobbio 1
Cerro Maggiore 1
Emeryville 1
Ennepetal 1
Hangzhou 1
Hayes 1
Irakleio 1
Istanbul 1
Jinan 1
La Canada Flintridge 1
Maniago 1
Mondolfo 1
New Delhi 1
Nola 1
Olomouc 1
Pannarano 1
Rende 1
Riga 1
Salandra 1
San Francisco 1
Saviano 1
Shanghai 1
Tabriz 1
Villaricca 1
Zhengzhou 1
Totale 459
Salva come PNG Salva come JPEG
Nome #
Novel Non-Peptide Small Molecules Preventing IKKβ/NEMO Association Inhibit NF-κB Activation in LPS-Stimulated J774 Macrophages 44
Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities 41
Ligand-based chemoinformatic discovery of a novel small molecule inhibitor targeting CDC25 dual specificity phosphatases and displaying in vitro efficacy against melanoma cells 39
A compound-based proteomic approach discloses 15-ketoatractyligenin methyl ester as a new PPARγ partial agonist with anti-proliferative ability 37
App maturation and intracellular localization are controlled by a specific inhibitor of 37/67 kda laminin-1 receptor in neuronal cells 37
Discovery of a Novel Small Molecule Inhibitor Targeting the Frataxin/Ubiquitin Interaction via Structure-Based Virtual Screening and Bioassays 35
Cdc25 inhibitors in melanoma cells 35
Discovery of Novel Naphthylphenylketone and Naphthylphenylamine Derivatives as Cell Division Cycle 25B (CDC25B) Phosphatase Inhibitors: Design, Synthesis, Inhibition Mechanism, and in Vitro Efficacy against Melanoma Cell Lines 34
In silico methods to address polypharmacology: Current status, applications and future perspectives 31
Small Molecule Drugs And Targeted Therapy For Melanoma: Current Strategies And Future Directions 27
null 26
The antiproliferative and proapoptotic effects of cladosporols A and B are related to their different binding mode as PPARγ ligands 25
Exploring the Role of N(6)-Substituents in Potent Dual Acting 5'-C-Ethyltetrazolyladenosine Derivatives: Synthesis, Binding, Functional Assays, and Antinociceptive Effects in Mice 25
Discovery Of Novel Peroxisome Proliferator-Activated Receptor γ (PPARγ) Scaffolds With Partial Agonist Binding Properties By Integrated In Silico/In Vitro Work Flow 24
Antitumor agents 7. Synthesis, antiproliferative activity and molecular modeling of new L-lysine-conjugated pyridophenoxazinones as potent DNA-binding ligands and topoisomerase IIα inhibitors 24
Easy access to α-ketoamides as SARS-CoV-2 and MERS Mpro inhibitors via the PADAM oxidation route 22
Identification of a new series of amides as non-covalent proteasome inhibitors 22
New diphenylmethane derivatives as peroxisome proliferator-activated receptor alpha/gamma dual agonists endowed with anti-proliferative effects and mitochondrial activity 22
Structural basis for PPAR partial or full activation revealed by a novel ligand binding mode 21
SARS-CoV-2 Entry Inhibitors: Small Molecules and Peptides Targeting Virus or Host Cells 21
In Silico Identification of Novel Inhibitors Targeting the Homodimeric Interface of Superoxide Dismutase from the Dental Pathogen Streptococcus mutans 18
Development of Novel Selective Peptidomimetics Containing a Boronic Acid Moiety, Targeting the 20S Proteasome as Anticancer Agents 18
Identification of the First PPARα/γ Dual Agonist Able to Bind to Canonical and Alternate Sites of PPARγ and to Inhibit its Cdk5-Mediated Phosphorylation 14
A Series of Ferulic Acid Amides Reveals Unexpected Peroxiredoxin 1 Inhibitory Activity with in vivo Antidiabetic and Hypolipidemic Effects 14
Novel Phenyldiazenyl Fibrate Analogues as PPAR α/γ/δ Pan-Agonists for the Amelioration of Metabolic Syndrome 14
Computational studies of SARS-CoV-2 3clpro: Insights from md simulations 14
Selective PPARγ modulators for Type 2 diabetes treatment: How far have we come and what does the future hold? 13
Chiral phenoxyacetic acid analogues inhibit colon cancer cell proliferation acting as PPARγ partial agonists 13
Optimization of peptidomimetic boronates bearing a P3 bicyclic scaffold as proteasome inhibitors 12
Exploring structural relationships between bioactive and commercial chemical space and developing target hypotheses for compound acquisition 12
Development of novel amides as noncovalent inhibitors of immunoproteasomes 12
Binding mode exploration of b1 receptor antagonists’ by the use of molecular dynamics and docking simulation—how different target engagement can determine different biological effects 11
Altered Local Interactions and Long-Range Communications in UK Variant (B.1.1.7) Spike Glycoprotein 11
A chemoinformatics search for peroxisome proliferator-activated receptors ligands revealed a new pan-agonist able to reduce lipid accumulation and improve insulin sensitivity 10
Characterization of novel inhibitors of CDC25 phosphatases: biochemical and biological analysis 9
Sulfonimide and amide derivatives as novel PPARα antagonists: Synthesis, antiproliferative activity, and docking studies 9
Novel inhibitors of signal transducer and activator of transcription 3 signaling pathway: an update on the recent patent literature 8
Recent advances in developing PCSK9 inhibitors for lipid-lowering therapy 8
“Molecular Anatomy”: a new multi-dimensional hierarchical scaffold analysis tool 8
Totale 820
Salva come PNG Salva come JPEG
Categoria #
all - tutte 1621
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1621
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201831 0000 00 00 25015
2018/201920 0061 04 70 1100
2019/202089 35413 31 00 413205
2020/202194 1014 3614 11 12798
2021/2022257 2368 1811 14 5335197
2022/2023210 36151723 1530 727 40000
Totale 820